Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,325
datasets available to search
ShareScore release 0.9.0
Dataset results
4,325 results for “real”
Endogenous Real Time Imaging Reveals Dynamic Chromosomal Mobility During ER-Mediated Transcriptional Burst Events [ChIP-seq]
GEO Series GSE221897. Homo sapiens. 12 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Real-time quantitative PCR analysis of Nannochloropsis gaditana
GEO Series GSE210188. Nannochloropsis gaditana. 4 samples. Type: Expression profiling by RT-PCR.
Real-time quantitative PCR analysis of rat aorta samples after stent deployment
GEO Series GSE155793. Rattus norvegicus. 16 samples. Type: Expression profiling by RT-PCR.
Real-time quantitative PCR analysis of mouse colon samples [12 weeks]
GEO Series GSE126393. Mus musculus. 6 samples. Type: Expression profiling by RT-PCR.
Real-time quantitative PCR analysis of gene expression in the cerebellum of MeCP2 A140V mutant mice
GEO Series GSE35694. Mus musculus. 36 samples. Type: Expression profiling by RT-PCR.
Real-time quantitative PCR analysis of NF-kB, TNFR1, BRAF, MEK and NRF2 genes in human D24, MM418-C1 melanoma and HaCaT cells
GEO Series GSE206541. Homo sapiens. 14 samples. Type: Expression profiling by RT-PCR.
Real time quantitative PCR analysis of serum circulating miRNAs from patients with head and neck tumors.
GEO Series GSE143491. Homo sapiens. 90 samples. Type: Expression profiling by RT-PCR.
Real-time quantitative PCR analysis of mouse liver tissue and liver cells
GEO Series GSE202707. Mus musculus; Mus. 7 samples. Type: Expression profiling by RT-PCR.
Real-time quantitative PCR analysis of white spruce (Picea glauca) families with different growth rates
GEO Series GSE214171. Picea glauca. 69 samples. Type: Expression profiling by RT-PCR.
Innate tissue immunosurveillance by γδ T cells has real-time dependence on the T cell receptor [RNA-seq]
GEO Series GSE277903. Mus musculus. 23 samples. Type: Expression profiling by high throughput sequencing.
Endogenous Real Time Imaging Reveals Dynamic Chromosomal Mobility During ER-Mediated Transcriptional Burst Events [PRO-seq]
GEO Series GSE221898. Homo sapiens. 3 samples. Type: Other.
Exhaust emissions from a gasoline vehicle under real-world driving conditions
<p>Exhaust emissions from a gasoline vehicle under real-world driving conditions</p>
Dataset related to the article "Sex effect on efficacy of pulmonary vein cryoablation in patients with atrial fibrillation: data from the multicenter real-world 1STOP project"
<p>This record contains raw data related to the article "Sex effect on efficacy of pulmonary vein cryoablation in patients with atrial fibrillation: data from the multicenter real-world 1STOP project”</p> <p> </p> <p>ABSTRACT</p> <p>PURPOSE:</p> <p>Pulmonary vein isolation (PVI) using cryoablation (PVI-C) is a widespread therapy for treating symptomatic, recurrent atrial fibrillation (AF). The impacts of sex on efficacy and safety of PVI-C in a real-world clinical practice is lacking. In a multicenter prospective project, we evaluated whether clinical characteristics, procedure parameters, procedural complications, long-term AF recurrence rates, and/or AF-related symptoms differed according to sex in patients treated with PVI-C.</p> <p>METHODS:</p> <p>Data from the study population were collected in the framework of the 1STOP ClinicalService® project, involving 47 Italian cardiology centers. Multivariable statistical analyses were conducted to determine if any baseline clinical characteristics impacted the efficacy of PVI-C.</p> <p>RESULTS:</p> <p>From April 2012, 2125 patients (27% female, 59 ± 11 years, 73% paroxysmal AF, and mean left atrial diameter = 42 ± 8 mm) underwent PVI-C. According to baseline characteristics, women were more likely to be older, with higher clinical risk scores (e.g., CHA<sub>2</sub>DS<sub>2</sub>-VASc), and a higher number of tested antiarrhythmic drugs before the index PVI-C procedure. Male and female cohorts showed comparable procedure time (mean =&thinsp;107.7 ± 46.8 min) and a similar incidence of periprocedural complications (4.5% overall), even after adjustment for baseline characteristics (P =&thinsp;0.880). The multivariable analyses demonstrated that the strongest predictor of AF recurrences was sex (0.74; 95% CI 0.58-0.93; P =&thinsp;0.011). After propensity score adjustment, the hazard ratio from a multivariable model, which included age and AF type (persistent) as covariates, was 0.76 (0.60-0.97) (P =&thinsp;0.025).</p> <p>CONCLUSIONS:</p> <p>According to the 1STOP project, in a real-world setting, PVI-C was relatively safe regardless of the patient's sex; however, when considering efficacy of the procedure, female patients had a lower long-term efficacy in comparison to males.</p> <p>CLINICAL TRIAL REGISTRATION: <a href="http://clinicaltrials.gov/show/NCT01007474">NCT01007474</a>.</p> <p> </p> <p> </p> <p> </p>
Clinical management and relevance of an alert feature for real-time symptom management in a mobile tool for self-monitoring and self-management of symptoms during anticancer treatment
<p>This dataset reports data from a descriptive study exploring the impact, clinical characteristics and clinical relevance of an alert feature for real-time symptom management in a mobile tool for self-monitoring and self-management of symptoms during anticancer treatment</p>
When Virtual Feels Real: Comparing Emotional Responses and Presence in Virtual and Natural Environments
<p>When Virtual Feels Real: Comparing Emotional Responses and Presence in Virtual and Natural Environments</p>
Dataset related to the article "A comparison of acute procedural outcomes within four generations of cryoballoon catheters utilized in the real-world multicenter experience of 1STOP"
<p>This record contains raw data related to the article “A comparison of acute procedural outcomes within four generations of cryoballoon catheters utilized in the real-world multicenter experience of 1STOP".</p> <p> </p> <p><strong>Abstract</strong></p> <p><strong>Introduction: </strong>Four generations of the cryoballoon (CB) catheter were retrospectively evaluated in a real-world examination of patients with atrial fibrillation (AF).</p> <p><strong>Methods and results: </strong>Four hundred eighty patients (27% female and 60 ± 10 years) suffering from AF, underwent pulmonary vein (PV) ablation with one-of-four generations of the CB catheter. The total cohort was divided into four groups of patients: 120 with first-generation (CB-1); 120 with second-generation (CB-2); 120 with third-generation (CB-3); and 120 with fourth-generation (CB-4). Equal group sizes were achieved by examining the last 120 patients treated in each cohort, attempting to minimize the effect of a learning curve between the generations of CB catheter. Baseline clinical and patient characteristics were similar between the four cohorts, excepting age and the number of tested antiarrhythmic drugs. Procedure, fluoroscopy, and left atrial dwell times were significantly lower in the CB-4 cohort compared to previous generations of the CB catheters, while the acute procedural success rate was comparable across all catheter groups (>99%). Total acute procedural complications were low (2.5%), and acute complications were comparable within the CB-2, CB-3, and CB-4 groups (0.8% reported in each cohort). The rate of time-to-isolation (TTI) visualization increased with later generations of the CB catheters.</p> <p><strong>Conclusions: </strong>The novel CB-4 achieved significantly faster procedural ablation times in comparison to the previous generations, while still maintaining a low rate of acute complications. Also, the rate of TTI visualization was observed to be higher with the CB-4 catheter. Further long-term evaluation is necessary, including an assessment of AF recurrence and PV reconnection(s).</p>
Dataset for the statistical analysis of the paper BONE DAMAGE AFTER CHEMOTHERAPY FOR LYMPHOMA: A REAL-WORLD EXPERIENCE
<p>Dataset used for the statistical analysis of the data to be published in a paper entitled "BONE DAMAGE AFTER CHEMOTHERAPY FOR LYMPHOMA: A REAL-WORLD EXPERIENCE"</p>
Dataset related to article "Connecting the use of innovative treatments and glucocorticoids with the multidisciplinary evaluation through rule-based natural-language processing: a real-world study on patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis"
<p>This record contains raw data related to article "Connecting the use of innovative treatments and glucocorticoids with the multidisciplinary evaluation through rule-based natural-language processing: a real-world study on patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis"</p><p>Abstract</p><p>Background: The impact of a multidisciplinary management of rheumatoid arthritis (RA), psoriatic arthritis (PsA), and psoriasis on systemic glucocorticoids or innovative treatments remains unknown. Rule-based natural language processing and text extraction help to manage large datasets of unstructured information and provide insights into the profile of treatment choices.</p><p>Methods: We obtained structured information from text data of outpatient visits between 2017 and 2022 using regular expressions (RegEx) to define elastic search patterns and to consider only affirmative citation of diseases or prescribed therapy by detecting negations. Care processes were described by binary flags which express the presence of RA, PsA and psoriasis and the prescription of glucocorticoids and biologics or small molecules in each cases. Logistic regression analyses were used to train the classifier to predict outcomes using the number of visits and the other specialist visits as the main variables.</p><p>Results: We identified 1743 patients with RA, 1359 with PsA and 2,287 with psoriasis, accounting for 5,677, 4,468 and 7,770 outpatient visits, respectively. Among these, 25% of RA, 32% of PsA and 25% of psoriasis cases received biologics or small molecules, while 49% of RA, 28% of PsA, and 40% of psoriasis cases received glucocorticoids. Patients evaluated also by other specialists were treated more frequently with glucocorticoids (70% vs. 49% for RA, 60% vs. 28% for PsA, 51% vs. 40% for psoriasis; p < 0.001) as well as with biologics/small molecules (49% vs. 25% for RA, 64% vs. 32% in PsA; 51% vs. 25% for psoriasis; p < 0.001) compared to cases seen only by the main specialist.</p><p>Conclusion: Patients with RA, PsA, or psoriasis undergoing multiple evaluations are more likely to receive innovative treatments or glucocorticoids, possibly reflecting more complex cases.</p><p> </p>
SLURP-Fr Real
<p><strong>Description</strong></p><p>This is the real test portion of the SLURP-Fr dataset, which is a part of the dataset created for the studies on interpreter-aided spoken language understanding (SLU) in the paper below, with three different parts:</p><ol><li>SLURP-Fr, an end-to-end SLU dataset based on the French portion of MASSIVE (<a href="https://github.com/alexa/massive">https://github.com/alexa/massive</a>), containing 16,521 synthetic audio samples created using Google TTS, accompanied with 477 real test samples collected from two French speakers at Idiap.</li><li>SLURP -Es, a similar dataset based on the parallel Spanish portion of MASSIVE, containing only synthetic samples.</li><li>Spoken Gigaword, a speech summarization dataset generated from Gigaword (<a href="https://www.tensorflow.org/datasets/catalog/gigaword">https://www.tensorflow.org/datasets/catalog/gigaword</a>), containing 51,385 synthetic audio samples created using Google TTS.</li></ol><p> </p><p><strong>Reference</strong></p><p>If you use this dataset, please cite the following publication:</p><p><i>He, Mutian, and Philip N. Garner. "The Interpreter Understands Your Meaning: End-to-end Spoken Language Understanding Aided by Speech Translation." Findings of EMNLP 2023.</i></p>
Data for Development of a lifetime model for large format nickel-manganese-cobalt oxide-based lithium-ion cell validated using a real-life profile
Open the record for dataset details and reuse information.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.